Preliminary Clinical Trial Presentation for Stem Cell and Dementia Held by Beauty-Stem Biomedical and Tzu Chi Hospital in Los Angeles, CA
Amber Ophthalmics Announces First Patient Enrolled in NEXPEDE-1, a Phase 2/3 Clinical Trial Evaluating Nexagon for the Treatment of Persistent Corneal Epithelial Defects